Loading clinical trials...

MyVoice:Rheum Decision Aid for Women With Rheumatic Diseases | Clinical Trials | Clareo Health

COMPLETEDNA

MyVoice:Rheum Decision Aid for Women With Rheumatic Diseases

A Pilot Study of the MyVoice:Rheum Decision Aid to Address the Reproductive Health Needs of Women With Rheumatic Diseases

NCT04879745•University of Pittsburgh

View on ClinicalTrials.gov

Summary

This is a pilot trial to assess feasibility and acceptability of MyVoice:Rheum vs. a patient pamphlet among female patients ages 18-44 (n=40) who receive rheumatology care. • Hypothesis: MyVoice:Rheum will be feasible and acceptable to patients who receive rheumatology care.

Detailed Description

The pilot will demonstrate if the MyVoice:Rheum decision aid can be feasibly and acceptably implemented into the rheumatology context and inform operational procedures for a future hybrid effectiveness-implementation trial. Women in the intervention arm will receive the MyVoice:Rheum decision aid (n=30). Women in the control arm (n=9) will receive a widely-accessible paper-based pamphlet about pregnancy, which, similarly to MyVoice:Rheum, targets women with a broad range of rheumatic diseases.

Eligibility

Age

18 - 44 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Patients must have at least one of four rheumatic diseases diagnosed by a rheumatologist: rheumatoid arthritis (RA), systemic sclerosis (SSc), myositis, Sjogren's syndrome, vasculitis, spondyloarthritis, and systemic lupus erythematosus (SLE).
•Patients must read and speak in English as a Spanish-language version of the tool has not yet been developed
•Access to a smart phone, personal computer, or tablet.

Exclusion Criteria

•Women who have had prior hysterectomy or sterilization, or are pregnant.

Locations (2)

UPMC Falk Rheumatology Clinic

Pittsburgh, Pennsylvania, United States

UPMC Lupus Center of Excellence

Pittsburgh, Pennsylvania, United States

Key Dates

Start Date

July 29, 2021

Primary Completion Date

December 31, 2022

Completion Date

March 1, 2023

Last Updated

April 30, 2024

Enrollment

ACTUAL participants

Conditions

Rheumatic DiseasesPhysician-Patient RelationsContraception

Interventions

MyVoice:Rheum

OTHER

Pamphlet

OTHER

Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery Study

NCT06345586

Contraception

View study

RECRUITING

Compassionate Care and Organization of Healthcare Services for a Successful Transition in Rheumatology

NCT07469787

Chronic Inflammatory Rheumatic Diseases of ChildhoodJuvenile-Onset Chronic Inflammatory Rheumatic Diseases+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 30, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

MyVoice:Rheum Decision Aid for Women With Rheumatic Diseases

Inclusion Criteria

Exclusion Criteria

Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery Study

Compassionate Care and Organization of Healthcare Services for a Successful Transition in Rheumatology

Effect of Different Sex Hormone Profiles for the Response to Physical Training

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

Rheumatology Patient Registry and Biorepository

Investigating Ovulation Inhibition for Use as a Contraceptive